|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 3.080 USD | +0.98% |
|
-1.91% | -9.68% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 8.125 | +163.8% | 8 | ||||||
| 295.18 | +7.3% | 28 | ||||||
| 202.47 | +16.4% | 15 | ||||||
| 340 | +17.08% | 3 | ||||||
| 43.5 | -11.06% | 8 | ||||||
| 27 | +64.73% | 5 | ||||||
| 57.86 | +68.34% | 7 | ||||||
| - | 92.03 | +50.9% | 2 | |||||
| - | - | 7.632 | +6.79% | 1 | ||||
| 6.025 | +71.16% | 2 | ||||||
| 9.75 | +20.52% | 4 | ||||||
| - | 297.5 | +67.98% | 2 | |||||
| - | 7.694 | +124.18% | 2 | |||||
| - | - | 9,000 | - | 1 | ||||
| 5.769 | +33.55% | 13 | ||||||
| - | 17.25 | -6.4% | 2 | |||||
| 12.39 | +54.06% | 11 | ||||||
| - | - | 23.44 | +35.81% | 1 | ||||
| Average | 580.76 | +46.18% | 6 | ||||||
| Weighted average by Cap. | 292.51 | +14.74% | 20 |
- Stock Market
- Stocks
- LFMD Stock
- Sector LifeMD, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
